Development and bioactivity evaluation of bioglasses with low Na2O content based on the system Na2O-CaO-MgO-P2O5-SiO2

被引:3
作者
El-Meliegy, Emad [2 ]
Hamzawy, Esmat M. A. [1 ]
El-Kady, Abeer M. [2 ]
Salama, Aida [3 ]
El-Rashedi, Ahalam [3 ]
机构
[1] Natl Res Ctr, Dept Glass Technol, Cairo, Egypt
[2] Natl Res Ctr, Dept Biomat, Cairo, Egypt
[3] Al Azhar Univ, Dept Biophys, Fac Sci Girls, Cairo, Egypt
关键词
IN-VITRO BIOACTIVITY; BEHAVIOR; GLASSES; PH;
D O I
10.1007/s10856-012-4681-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Osteoconductive bioglasses, free of K2O and Al2O3 and with content of Na2O lower than 10 mol%, were designed based on the ratio (SiO2 + MgO)/(P2O5 + CaO + Na2O) in the system Na2O-CaO-MgO-P2O5-SiO2. The developed glasses have shown a strong potential for the formation of hydroxycarbonated apatite (HCA) in vitro. The particles of HCA aggregates tend to be of finer size with increasing the ratio of (SiO2 + MgO)/(CaO + P2O5 + Na2O) in the glass chemical composition indicating significant bioactivity. Critical size bone defects created in the femurs of albino adult female rats, and grafted with the glass particles for 12 weeks post implantation, were completely healed by filling with mineralized bone matrix without infection showing a strong potential for new bone formation in vivo. Osteoblasts and osteocytes were observed close to the surface of the granular implants with active areas of bone deposition, resorption and remodelling. The bioglass with lowest (SiO2 + MgO)/(CaO + P2O5 + Na2O) ratio has shown the highest bioactivity while the bioglass with the highest (SiO2 + MgO)/(CaO + P2O5 + Na2O) has shown the lowest bioactivity. The newly formed bone in vivo has shown a similar structure to that of the original bone as indicated by the histology and microstructural results. In addition, Ca/P molar ratio of the newly formed bone was found to be (similar to 1.67), which is similar to that of the original bone.
引用
收藏
页码:2069 / 2080
页数:12
相关论文
共 23 条
[1]   Influence of morphology on in vitro compatibility of bioactive glasses [J].
Andrade, Angela L. ;
Valerio, Patricia ;
Goes, Alfredo M. ;
Leite, Maria de Fatima ;
Domingues, Rosana Z. .
JOURNAL OF NON-CRYSTALLINE SOLIDS, 2006, 352 (32-35) :3508-3511
[2]   Development and in vitro characterization of sol-gel derived CaO-P2O5-SiO2-ZnO bioglass [J].
Balamurugan, Anbalagan ;
Balossier, Gerard ;
Kannan, Sanjeevi ;
Michel, Jean ;
Rebelo, Avito H. S. ;
Ferreira, Jose M. F. .
ACTA BIOMATERIALIA, 2007, 3 (02) :255-262
[3]   Bioactive fluorapatite-containing glass ceramics [J].
Bogdanov, B. I. ;
Pashev, P. S. ;
Hristov, J. H. ;
Markovska, I. G. .
CERAMICS INTERNATIONAL, 2009, 35 (04) :1651-1655
[4]   Effect of pH and ionic strength on the reactivity of Bioglass® 45S5 [J].
Cerruti, M ;
Greenspan, D ;
Powers, K .
BIOMATERIALS, 2005, 26 (14) :1665-1674
[5]  
El-Ghannam A, 2001, J BIOMED MATER RES, V55, P387, DOI 10.1002/1097-4636(20010605)55:3<387::AID-JBM1027>3.0.CO
[6]  
2-V
[7]   Study of the bioactivity of fluorophlogopite-whitlockite ceramics [J].
El-Meliegy, E. M. ;
El-Bassyouni, G. T. .
CERAMICS INTERNATIONAL, 2008, 34 (06) :1527-1532
[8]   The story of Bioglass® [J].
Hench, Larry L. .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2006, 17 (11) :967-978
[9]  
Hill RG, 2009, US Patent, Patent No. 0208428
[10]   Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions [J].
Huang, Wenhai ;
Day, Delbert E. ;
Kittiratanapiboon, Kanisa ;
Rahaman, Mohamed N. .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2006, 17 (07) :583-596